4.6 Article

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis

Journal

JOURNAL OF LIPID RESEARCH
Volume 63, Issue 1, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.jlr.2021.100157

Keywords

apolipoprotein(s); apolipoprotein E; LPL; lipoprotein metabolism; lipoproteins; VLDL; chylomicrons; metabolic disease; TG-rich lipoproteins; lipolysis

Funding

  1. Institutional National Research Service Award [(T32) 1T32HL125204-01, RO1 HL155601]

Ask authors/readers for more resources

High levels of circulating triglycerides are associated with metabolic diseases. This study found that APOE on VLDL modulates LPL activity, which may be relevant to the pathogenesis of metabolic diseases.
High levels of circulating triglycerides (TGs), or hypertriglyceridemia, are key components of metabolic diseases, such as type 2 diabetes, metabolic syndrome, and CVD. As TGs are carried by lipoproteins in plasma, hypertriglyceridemia can result from overproduction or lack of clearance of TG-rich lipoproteins (TRLs) such as VLDLs. The primary driver of TRL clearance is TG hydrolysis mediated by LPL. LPL is regulated by numerous TRL protein components, including the cofactor apolipoprotein C-II, but it is not clear how their effects combine to impact TRL hydrolysis across individuals. Using a novel assay designed to mimic human plasma conditions in vitro, we tested the ability of VLDL from 15 normolipidemic donors to act as substrates for human LPL. We found a striking 10-fold difference in hydrolysis rates across individuals when the particles were compared on a protein or a TG basis. While VLDL TG contents moderately correlated with hydrolysis rate, we noticed substantial variations in non-apoB proteins within these particles by MS. The ability of LPL to hydrolyze VLDL TGs did not correlate with apolipoprotein C-II content, but it was strongly inversely correlated with apolipoprotein E (APOE) and, to a lesser extent, apolipoprotein A-II. Addition of exogenous APOE inhibited LPL lipolysis in a dose-dependent manner. The APOE3 and (particularly) APOE4 isoforms were effective at limiting LPL hydrolysis, whereas APOE2 was not. We conclude that APOE on VLDL modulates LPL activity and could be a relevant factor in the pathogenesis of metabolic disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available